These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 2061177)

  • 1. Efficacy of mitoxantrone against various neoplasms in dogs.
    Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Straw RC; Dickinson K; Cooper MF; Withrow SJ
    J Am Vet Med Assoc; 1991 May; 198(9):1618-21. PubMed ID: 2061177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of doxorubicin for treatment of various canine neoplasms.
    Ogilvie GK; Reynolds HA; Richardson RC; Withrow SJ; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1580-3. PubMed ID: 2599941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.
    Ogilvie GK; Moore AS; Obradovich JE; Elmslie RE; Vail DM; Straw RC; Salmon MD; Klein MK; Atwater SW; Ciekot PE
    J Am Vet Med Assoc; 1993 Jun; 202(11):1839-44. PubMed ID: 8320152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors.
    Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Curtis CR; Straw RC; Dickinson K; Cooper MF; Withrow SJ
    J Am Vet Med Assoc; 1991 May; 198(9):1613-7. PubMed ID: 2061176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study.
    Ogilvie GK; Moore AS; Chen C; Ciekot PA; Atwater SW; Bergman PJ; Walters LM
    J Am Vet Med Assoc; 1994 Aug; 205(4):570-3. PubMed ID: 7961092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
    Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
    J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
    Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
    J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.
    Ogilvie GK; Vail DM; Klein MK; Powers BE; Dickinson K
    J Am Vet Med Assoc; 1991 May; 198(10):1762-4. PubMed ID: 2071476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.
    Henry CJ; McCaw DL; Turnquist SE; Tyler JW; Bravo L; Sheafor S; Straw RC; Dernell WS; Madewell BR; Jorgensen L; Scott MA; Higginbotham ML; Chun R
    Clin Cancer Res; 2003 Feb; 9(2):906-11. PubMed ID: 12576466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
    Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
    J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of isotretinoin and etretinate for the treatment of benign cutaneous neoplasia and cutaneous lymphoma in dogs.
    White SD; Rosychuk RA; Scott KV; Trettien AL; Jonas L; Denerolle P
    J Am Vet Med Assoc; 1993 Feb; 202(3):387-91. PubMed ID: 8440627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
    Upton ML; Tangner CH; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006).
    Bannink EO; Sauerbrey ML; Mullins MN; Hauptman JG; Obradovich JE
    J Am Vet Med Assoc; 2008 Aug; 233(3):446-51. PubMed ID: 18673031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor evaluation of benzaldehyde in the dog and cat.
    MacEwen EG
    Am J Vet Res; 1986 Feb; 47(2):451-2. PubMed ID: 3954233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model.
    Hershey AE; Kurzman ID; Forrest LJ; Bohling CA; Stonerook M; Placke ME; Imondi AR; Vail DM
    Clin Cancer Res; 1999 Sep; 5(9):2653-9. PubMed ID: 10499645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors.
    Ogilvie GK; Richardson RC; Curtis CR; Withrow SJ; Reynolds HA; Norris AM; Henderson RA; Klausner JS; Fowler JD; McCaw D
    J Am Vet Med Assoc; 1989 Dec; 195(11):1584-7. PubMed ID: 2599942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.